Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jtcvs.2018.06.030 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A profile of the impella 5.5 for the clinical management of cardiogenic shock and a review of the current indications for use and future directions.
Expert Rev Med Devices
December 2024
Department of Cardiothoracic and Vascular Surgery, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Introduction: The Impella 5.5 device is a surgically inserted, trans-valvular, microaxial flow device capable of providing 5.5 L/min of continuous, antegrade flow from the left ventricle (LV) to the aorta.
View Article and Find Full Text PDFOutcomes after hospital discharge in children requiring post-cardiotomy extracorporeal membrane oxygenation: A binational retrospective cohort study.
J Thorac Cardiovasc Surg
November 2024
Faculty of Medicine, University of Queensland, Brisbane, Australia; Department of Cardiac Surgery, Queensland Children's Hospital, Brisbane, Australia. Electronic address:
Objectives: To describe longer-term survival and morbidity outcomes after hospital discharge in a binational cohort of children who required extracorporeal membrane oxygenation after cardiac surgery.
Methods: This was a retrospective cohort study from the Australia and New Zealand Congenital Outcomes Registry for Surgery database. All patients younger than 18 years of age (n = 12,290) undergoing pediatric cardiac surgical procedures between January 1, 2013, and December 31, 2021, who required post-cardiotomy extracorporeal membrane oxygenation in the same admission were included.
Potential Impact of Direct Versus Indirect Central Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO) Cannulation in Refractory Postcardiotomy Cardiogenic Shock.
Cureus
September 2024
Department of Cardiac Surgery, University Hospital Erlangen, Friedrich-Alexander-University, Erlangen, DEU.
Article Synopsis
- * Results showed that patients who received icECMO had a significantly higher 30-day survival rate (40%) compared to those who underwent dcECMO (14.3%), despite similar initial ECMO flow rates and RPMs.
- * Additional findings revealed that higher lactate levels and gastrointestinal ischemia were more prevalent in the dcECMO group, and arterial lactate levels on the first day were identified as a key risk factor for 30-day mortality.
A comparative study of femoral artery and combined femoral and axillary artery cannulation in veno-arterial extracorporeal membrane oxygenation patients.
Front Cardiovasc Med
September 2024
Department of Cardiac Surgery, The First Hospital of China Medical University, Shenyang, China.
Objective: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is a critical support technique for cardiac surgery patients. This study compares the outcomes of femoral artery cannulation vs. combined femoral and axillary artery cannulation in post-cardiotomy VA-ECMO patients.
View Article and Find Full Text PDFCentral versus peripheral VA ECMO for cardiogenic shock: an 8-year experience of a tertiary cardiac surgery center in Greece.
Hellenic J Cardiol
September 2024
Cardiac Surgery Intensive Care Unit, Onassis Cardiac Surgery Center, Athens, Greece. Electronic address:
Background: Venoarterial extracorporeal membrane oxygenation (VA ECMO) has emerged as an effective rescue therapy in patients with cardiogenic shock refractory to standard treatment protocols, and its use has been rising worldwide in the last decade. Although experience and availability are growing, outcomes remain poor. There is need for evidence to improve clinical practice and outcomes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!